<http://schema.org/description>
"The drug rituximab, an antibody that targets the immune system and is often used to treat immune disorders such as lymphoma and arthritis, has recently emerged as a potential treatment for a childhood kidney disorder known as idiopathic nephrotic syndrome (INS). While the cause of INS is not fully known, it is believed to be an immune disorder. Unfortunately, rituximab does not appear to benefit children who have INS that is resistant to standard treatments, according to a study appearing in an upcoming issue of new study in the Journal of the American Society of Nephrology (JASN)."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2012-05-immune-drug-doesnt-kids-hard-to-treat.html>